Patrick Wingrove

Skip to main content

Author

Patrick Wingrove

Thomson Reuters

24 results

LegalcategoryDrugmakers set strategy for legal fight against US pricing regulationMay 9, 2023
BusinesscategoryModerna reports surprise profit as it books deferred COVID vaccine salesMay 4, 2023
Healthcare & PharmaceuticalscategoryDrugmakers scout for deals, ramp up research spendingApril 27, 2023
BusinesscategoryAbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fallApril 27, 2023
BusinesscategoryNovavax cut $50 million in costs, plans to slash more, CEO saysApril 12, 2023
Healthcare & PharmaceuticalscategoryModerna says flu shot misses early success bar, but expects 2024 revenueApril 11, 2023
FOCUSAs weight-loss drugs hit the U.S. market, doctors debate how to use themMarch 30, 2023
BusinesscategoryFactbox: New recommendations for weight-loss drugsMarch 30, 2023
BusinesscategoryFDA's Marks hopes to align global regulators to boost gene therapyMarch 29, 2023
LegalcategoryAmgen-Sanofi patent case divides makers of antibody drugsMarch 27, 2023
BusinesscategoryModerna CEO defends $130 US COVID vaccine price in Senate hearingMarch 22, 2023
BusinesscategoryModerna expects to price its COVID vaccine at about $130 in the USMarch 21, 2023
Future of HealthcategorySanofi to cut US price of its most-prescribed insulin by 78%March 16, 2023
Healthcare & PharmaceuticalscategoryNovo Nordisk to slash US insulin prices, following move by Eli LillyMarch 14, 2023
BusinesscategorySVB fall casts shadow on early-stage U.S. biotechMarch 13, 2023
Future of HealthcategoryBristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiationMarch 13, 2023
Healthcare & PharmaceuticalscategoryBayer plans to spend $1 bln on US pharma R&D in 2023-US pharma headMarch 10, 2023
Healthcare & PharmaceuticalscategoryLilly to cut some list prices by 70% and offer $25 insulinMarch 2, 2023
Future of HealthcategoryModerna flu vaccine delivers mixed results in trial, shares fallFebruary 17, 2023
FOCUSDrug companies face COVID cliff in 2023 as sales set to plummetFebruary 6, 2023

1 to 20 of 24